FA
THRX

Forefront Analytics’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Forefront Analytics’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,672
Closed -$47.5K – 70
2023
Q3 		$47.5K Buy
+17,672
New +$47.5K 0.03% 66
2022
Q4 		– Sell
-13,065
Closed -$74K – 80
2022
Q3 		$74K Buy
+13,065
New +$74K 0.04% 55